Expanding the treatment options for influenza

JAMA. 2000 Feb 23;283(8):1057-9. doi: 10.1001/jama.283.8.1057.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acetamides / economics
  • Acetamides / therapeutic use*
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Cost of Illness
  • Cost-Benefit Analysis
  • Enzyme Inhibitors / economics
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Influenza, Human / drug therapy*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control
  • Neuraminidase / antagonists & inhibitors*
  • Oseltamivir

Substances

  • Acetamides
  • Antiviral Agents
  • Enzyme Inhibitors
  • Oseltamivir
  • Neuraminidase